| Dear Reader, Patrick Cox here. Today is the final day of Action Week, so let’s discuss a subject everyone must know about—both as an investor and as a human being. Most revolutions don’t start with a bang but with a whisper. It’s the same with today’s biotech revolution. The aging Baby Boomers are the richest, largest, and most influential generation. What they want more than anything is a longer, healthier life... and by God, they’re going to get it. Scientists are feverishly working on novel gene-based therapies that could extend people’s healthy lifespans by decades—and Boomers are pushing hard to bring those therapies to market. In this Bull or Bust interview titled "Anti-Aging and Health: The Most Desirable Commodity," I discuss with Mauldin Publisher Ed D’Agostino why I believe anti-aging medicine is the Holy Grail for savvy investors... and the important developments to keep your eyes on. I’ll also give you the details of one of the companies we are following in the TransTech Alert, my premium alert service for early-stage biotech stocks in the health sector. Normally, we don’t give away our portfolio stocks to protect our paid subscribers’ interests. After all, at $1,995 per year, a TransTech Alert subscription isn’t cheap. But we’re making an exception today. You should know that this company is especially dear to my heart because its anti-aging products are already widely available. Watch the video here. It will only be available online for 36 hours, so don’t miss out. Sincerely,
Patrick Cox
Editor, Transformational Technology Alert
| 